| 2006D-0383 | Characterization and Qualification of Cell Substrates and Other Biological Starting Materials Used in the Production of Viral Vaccines for the Prevention and Treatment of Infectious Diseases | |||||||||||||||||||||||
| FDA Comment Number : | EC3402 | |||||||||||||||||||||||
| Submitter : | Mr. Robert Harrold | Date & Time: | 12/18/2006 09:12:44 | |||||||||||||||||||||
| Organization : | Mr. Robert Harrold | |||||||||||||||||||||||
| Category : | Individual Consumer | |||||||||||||||||||||||
| Issue Areas/Comments | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| GENERAL | ||||||||||||||||||||||||
| I object to any fetus serving as the source for any medicine or other commercial product. I believe that aborting life is wrong, and fear that permitting the proposed use of a fetus in this manner will lead to increased abortions due to the expected increase in the commercial value of a fetus. | ||||||||||||||||||||||||